Maridebart cafraglutide

Clinical trial
Calculate Dose

For research use only.

Key Facts

CAS
2760218-55-9
Molecular Weight (MW)
โ‰ˆ145โ€“154 kDa (conjugate; assay-dependent)
Half-life
Long (monthly or less frequent dosing in trials)
Unit
mcg
Administration Route
Subcutaneous
Frequency
Monthly or less frequent (per study arm)
Last updated
12/14/2025

Overview

โ€”

Protocol

Dosage Range
Per trial protocol
Frequency
Monthly or less frequent (per study arm)
Cycle
Per study
Administration Route
Subcutaneous
Reconstitution Guide
โ€”

Science

Mechanism of Action

Mechanism of action not fully established in publicly available sources.

Studies are being curated for this entry.

Suggest a study

Benefits

Therapeutic benefits not fully established.

Potential Side Effects

  • Side effects not fully established.

References

References coming soon.

Suggest a reference

Related peptides